cefotiam has been researched along with ritonavir in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aksoydan, B; Avsar, T; Calis, S; Dogan, B; Durdagi, S; Iyison, NB; Orhan, MD; Sahin, K; Shahraki, A | 1 |
1 other study(ies) available for cefotiam and ritonavir
Article | Year |
---|---|
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2: A Combined in silico and in vitro Study.
Topics: Angiotensin-Converting Enzyme 2; Antiviral Agents; Cefotiam; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; Drugs, Investigational; Humans; Molecular Docking Simulation; Ritonavir; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |